Cue Biopharma Headquarters
The links below provide all the necessary information about Cue Biopharma Headquarters. Also there you will find information about the address, phone numbers, emails and much more.
Immune Responses, On Cue - Cue Biopharma
- https://www.cuebiopharma.com/
- Cue Biopharma 40 Guest Street Boston, MA 02135 TEL 617-949-2680. Business Development: [email protected] Media: [email protected] Investor Relations: [email protected] . Legal | Privacy | …
Contact Us - Cue Biopharma
- https://www.cuebiopharma.com/contact-us/
- Cue Biopharma. 40 Guest Street. Boston, MA 02135. TEL 617-949-2680. Business Development: [email protected]. Media: [email protected]. Investor Relations: [email protected].
About Us - Cue Biopharma
- https://www.cuebiopharma.com/about-us/
- Cue Biopharma 40 Guest Street Boston, MA 02135 TEL 617-949-2680. Business Development: [email protected] Media: [email protected] Investor Relations: [email protected] . Legal | Privacy | Cookies
Cue Biopharma Company Profile - Craft
- https://craft.co/cue-biopharma
- Cue Biopharma has an office in Cambridge Open Map View Cambridge, MA, US (HQ) 21 Erie St Show all (1) Report incorrect company information Cue Biopharma Financials and Metrics Cue Biopharma Revenue Cue Biopharma's revenue was reported to be $3.15 m in FY, 2020 Summary Cue Biopharma's current market capitalization is $172.3 m. Income Statement
Cue Biopharma - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/cue-biopharma
- Where is Cue Biopharma 's headquarters? Cue Biopharma is located in Cambridge, Massachusetts, United States. Who invested in Cue Biopharma? …
Cue Biopharma - Overview, News & Competitors
- https://www.zoominfo.com/c/cue-biopharma-inc/402671940
- Cue Biopharma’s headquarters are in 21 Erie St, Cambridge, Massachusetts, 02139, United States What is Cue Biopharma’s phone number? Cue Biopharma’s phone number is (617) 949-2680
Cue Biopharma - MDB Capital Holdings
- https://www.mdb.com/companies/cue-biopharma/
- Headquartered in Cambridge, MA, we are led by an experienced management team and scientific and clinical advisory board (SAB/CAB) with deep expertise in the design and clinical development of protein biologics, immunology and immuno-oncology. Year Founded: 2014. Status: IPO.
Cue Biopharma | LinkedIn
- https://www.linkedin.com/company/cuebiopharma
- headquartered in cambridge, massachusetts, we are led by an experienced management team and independent board of directors with deep expertise in …
Cue Biopharma Inc - Company Profile and News
- https://www.bloomberg.com/profile/company/CUE:US
- Cue Biopharma, Inc. operates as a bio-technology company. The Company discovers and develops medicines for cancers and autoimmune diseases. Cue Biopharma focuses on design and clinical development ...
Diagnostic testing at the speed of life | Cue
- https://www.cuehealth.com/
- Your health in the palm of your hands. The Cue Integrated Care Platform is designed to revolutionize the way we access healthcare at home, at work, or at the point of care. Our connected, portable, and accurate diagnostic system provides real-time, actionable health data, which we believe will drive better outcomes. Learn about our products.
Cue Biopharma Reports First Quarter 2022 Financial Results
- https://finance.yahoo.com/news/cue-biopharma-reports-first-quarter-203000775.html
- 8 hours ago · BOSTON, May 10, 2022 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and ...
Cue Biopharma Stock Forecast, Price & News (NASDAQ:CUE)
- https://www.marketbeat.com/stocks/NASDAQ/CUE/
- The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Did you find out everything you wanted about Cue Biopharma Headquarters?
We are sure that the information collected for you about Cue Biopharma Headquarters turned out to be more than enough.
